UZ Leuven
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1971-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- https://www.uzleuven.be/nl
Clinical Trials
24
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (24 trials with phase data)• Click on a phase to view related trials
News
eXmoor Pharma and KU Leuven Form Strategic Alliance to Accelerate AAV Gene Therapy Development
eXmoor Pharma and KU Leuven have established a strategic partnership to support a new cell and gene therapy hub, focusing on accelerating AAV gene therapies from bench to first-in-human trials.
Hybrid Closed-Loop Systems Show Significant Glycemic Benefits for Pregnant Women with Type 1 Diabetes
Two major clinical trials demonstrate that hybrid closed-loop insulin delivery systems significantly improve time in range and reduce hypoglycemia in pregnant women with type 1 diabetes compared to standard care.
KU Leuven and UZ Leuven Launch €14 Million Advanced Therapy Production Facility
KU Leuven and UZ Leuven are investing €14 million to establish an Advanced Therapy Medicinal Products (ATMP) facility on the Gasthuisberg campus, scheduled to be operational by late 2025.